US to trial Star Wars-like headgear to spot brain injuries in a snap on battlefields
The clinical trials are slated to begin in June 2025, they will aim to ascertain the capabilities of the device.
The Department of Defense (DoD) has awarded Sense Neuro Diagnostics a contract to conduct the clinical trials of the NeuroHawk device.
The NeuroHawk device is designed to detect hemorrhage in specific regions of the brain and provide rapid diagnosis of traumatic brain injury on the front lines of care.
The $2 million contract has been awarded by the US DoD Congressionally Directed Medical Research Programs (CDMRP) through the Traumatic Brain Injury and Psychological Health Research Program (TBI PHRP).
The clinical trial, set to begin in June 2025, will evaluate the capabilities of the NeuroHawk device to diagnose TBI and localize brain hemorrhage, offering critical insights in high-pressure environments.
NeuroHawk device for traumatic brain injury
The NeuroHawk device is a non-invasive brain scanner that utilizes advanced, low-power radio frequency (RF) technology to detect and monitor TBI and brain hemorrhage in seconds, as per Sense Neuro Diagnostics.
It aims to provide healthcare professionals with the information needed to make critical treatment decisions faster and more accurately.
The medical technology company states that this rapid, objective diagnosis capability could significantly improve triage and treatment decisions on the battlefield, reducing the risk of secondary injury and improving outcomes for those with the most acute needs.
Article